Make content about: Christine found hope in a new drug
Christine was told her illness was life-limiting, but access to a new treatment has kept her stable.
This story
In July 2023, Christine learned that her diagnosis had become life-limiting. After gaining access to a new drug called bevacizumab, her condition has remained stable since May 2024.
Where you could take it
Sit down with Christine to hear what it was like receiving access to bevacizumab and how she spends her time today.
The charity
- Charity: Target Ovarian Cancer
- Registration number: 1125038
- Based in: London, England